Optimized Daily Report

PCAC day 1: panel recommends lifting limits on BPC-157, KPV, and restricted peptides

ODR Daily Brief: 2026-07-25

Hims exits compounded semaglutide; branded GLP-1 floor lands at $249

California's $4.5M Carbon Health settlement puts MSO-PC structures on the enforcement map

California's $4.5M Carbon Health settlement puts clinic corporate structure on the enforcement map, plus the FDA's staff review of wellness peptides.

Issue 001: FDA staff recommended against all seven peptides before the PCAC vote

ODR Daily Brief: 2026-07-08